Join
Live feed
·
INSIDERFilingvia Quantisnow
Cellectar Biosciences Inc. logo

Chief Operating Officer Longcor Jarrod bought $8,400 worth of shares (30,000 units at $0.28), increasing direct ownership by 56% to 83,141 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLRB· Cellectar Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLRB (Cellectar Biosciences Inc.) and more on Quantisnow.